Xu, Z., Wu, D., Fu, D., Tang, C., Ge, J., Zhang, Z. and Zhou, W. 2020. Nobiletin inhibits viability of human renal carcinoma cells via the JAK2/STAT3 and PI3K/Akt pathway. Cellular and Molecular Biology. 66, 5 (Jul. 2020), 199–203. DOI:https://doi.org/10.14715/cmb/2020.66.5.33.